Plain-English translation of NCT07714018 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two different weight loss approaches for people with early-stage kidney cancer who are being monitored rather than immediately treated. The study wants to see whether losing weight through either calorie restriction or intermittent fasting can help slow down tumor growth and prevent the need for surgery. Both programs last 6 months and include behavioral support and exercise guidance.
Research suggests that weight loss might help slow the progression of small kidney tumors, but doctors don't yet know which approach works best for kidney cancer patients. This trial will help determine if lifestyle changes can be an effective tool to prevent cancer progression and delay more invasive treatment.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two 6-month weight loss programs. One program focuses on calorie restriction (eating fewer calories overall), while the other includes intermittent fasting with two fasting days per week. Both programs will guide you through behavioral changes and exercise, and the research team will track your weight, diet, body composition, and how your tumor is responding over time.
AI-generated summary from trial data · Sep 16, 2026 · Not medical advice
United States